Their ability to cross the blood–brain barrier and modulate the Nrf2/Keap1/HO-1 pathways suggests neuroprotective roles in Alzheimer’s disease, Parkinson’s disease, and neuropathic pain [189,190]. Here, HMOX1 is linked to early-onset autosomal dominant Alzheimer disease.